Bharat Immunological Biological Corporation Ltd vs Zota Health Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 17.3 as of 06 May 15:30 . The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Zota Health Care Ltd changed from 84.1 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 years The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Zota Health Care Ltd changed from ₹ 340.16 crore on March 2021 to ₹ 2306 crore on March 2025 . This represents a CAGR of 46.64% over 5 years The revenue of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Zota Health Care Ltd for the Dec '25 is ₹ 144.67 crore as compare to the Sep '25 revenue of ₹ 130.58 crore. This represent the growth of 10.79% The ebitda of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Zota Health Care Ltd for the Dec '25 is ₹ 1.28 crore as compare to the Sep '25 ebitda of ₹ 7.96 crore. This represent the decline of -83.92% The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Zota Health Care Ltd changed from ₹ -12.72 crore to ₹ -29.64 crore over 7 quarters. This represents a CAGR of 62.16% The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zota Health Care Ltd changed from -1535 % on March 2021 to 33.23 % on March 2025 . This represents a CAGR of NaN% over 5 years .

About Bharat Immunological & Biological Corporation Ltd

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
BIBCOL was incorporated in 1989.
The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
BIBCL installed a plant of 100 mln units.
Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About Zota Health Care Ltd

Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products.
The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat.
The Company meets the requirements of millions of people by increasing access to high-quality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving India's pharmaceutical industry a boost. The Company has three business verticals: Marketing-a traditional business vertical, and driving business verticals - Exports and Retail harmacy Chain.
Through its chain, Davaindia, the largest private-sector generic pharmacy chain, the Company is making strong inroads into the generic retail pharmacy business.

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and Zota Health Care Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or Zota Health Care Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 74 Cr while Market cap of Zota Health Care Ltd is 4,559 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and Zota Health Care Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and Zota Health Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and Zota Health Care Ltd?

As of May 6, 2026, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹17.3. On the other hand, Zota Health Care Ltd stock price is INR ₹1316.4.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and Zota Health Care Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and Zota Health Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.